IDEXX (IDXX) Form 144: 5,450 Shares Registered ($3.55M)

IDEXX Laboratories Inc. filed a Form 144 to register the proposed sale of 5,450 shares of common stock, with an aggregate market value of $3,551,220.00, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

IDEXX Laboratories Inc. filed a Form 144 to register the proposed sale of 5,450 shares of common stock, with an aggregate market value of $3,551,220.00, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC. The filing lists 80,004,694 shares outstanding and shows an approximate sale date of 08/08/2025.

The shares were acquired via a stock option exercise on 08/08/2025 and paid in cash. The filer reports "Nothing to Report" for securities sold during the past three months and includes the standard attestation about material nonpublic information and trading-plan language. The provided content does not show a populated notice date or signature block.

Insights

Financial Analyst

TL;DR: Routine registration for an insider sale after an option exercise; size is very small relative to outstanding shares.

The Form 144 registers 5,450 common shares with an aggregate market value of $3,551,220, implying an approximate price of $651.13 per share based on the numbers disclosed. Relative to the 80,004,694 shares outstanding, the shares to be sold represent roughly 0.0068% of the outstanding float, indicating the transaction is unlikely to move the market. The sale is listed to be executed through Morgan Stanley Smith Barney LLC on NASDAQ, and the filer reports no sales in the prior three months.

Corporate Governance Expert

TL;DR: Filing contains standard insider-sale attestation and trading-plan language; document lacks populated notice date/signature in provided content.

The form includes the customary representation that the selling party is unaware of undisclosed material adverse information and references Rule 10b5-1 trading-plan language as part of the attestation. The filing documents acquisition via a stock option exercise and payment in cash, and indicates no other sales in the past three months. The provided copy does not display a completed notice date or signature, which are administrative elements typically present on a final filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What securities does IDEXX (IDXX) plan to sell according to this Form 144?

The filing registers the proposed sale of 5,450 shares of common stock.

When is the approximate sale date listed on the Form 144 for IDXX?

The approximate date of sale is 08/08/2025 as stated in the filing.

Through which broker will the IDXX shares be sold?

The broker listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

How were the shares acquired according to the Form 144?

The shares were acquired via a stock option exercise on 08/08/2025 and payment was made in cash.

What is the aggregate market value and how many shares outstanding are reported?

Aggregate market value is $3,551,220.00 and the filing shows 80,004,694 shares outstanding.

Were there any securities sold by the filer in the past three months?

The filing reports "Nothing to Report" for securities sold during the past three months.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 04:23 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001630353
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IDEXX LABORATORIES, INC
SEC File Number	000-19271
Address of Issuer	One IDEXX Drive Westbrook MAINE 04092
Phone	207-556-0300
Name of Person for Whose Account the Securities are To Be Sold	SHARON E UNDERBERG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5450	3551220.00	80004694	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/08/2025	Stock Option Exercise	Issuer			5450	08/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Sharon E Underberg
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)